Hepatitis B vaccine effectiveness in the face of global HBV genotype diversity

Recombinant hepatitis B vaccines are of the A2 genotype; one of ten known genotypes whose distribution varies globally. Reports of rare HBV infections in blood donors with an imbalance of non-A2 genotype HBV in vaccinated subjects have raised questions about the cross-protection afforded by HBV-A2 v...

Full description

Saved in:
Bibliographic Details
Published inExpert review of vaccines Vol. 10; no. 12; pp. 1709 - 1715
Main Authors Cassidy, Adrian, Mossman, Sally, Olivieri, Antonio, Ridder, Marc De, Leroux-Roels, Geert
Format Journal Article
LanguageEnglish
Published England Taylor & Francis 01.12.2011
Expert Reviews Ltd
Informa Healthcare
Subjects
Blood donors
Children
Cross-protection
Cross-reactivity
Data processing
Development and progression
effectiveness
Genetic aspects
Genetic Variation
Genotype
Genotypes
Health aspects
Hepatitis B
Hepatitis B - blood
Hepatitis B - immunology
Hepatitis B - prevention & control
Hepatitis B - virology
Hepatitis B Antibodies - blood
Hepatitis B Antibodies - immunology
Hepatitis B vaccine
Hepatitis B Vaccines - administration & dosage
Hepatitis B Vaccines - genetics
Hepatitis B Vaccines - immunology
Hepatitis B virus
Hepatitis B virus - genetics
Hepatitis B virus - immunology
Hepatitis B virus - pathogenicity
Humans
Infection
Prevention
recombinant vaccine
Reviews
Vaccination
vaccine
Vaccines
Vaccines, Synthetic - administration & dosage
Vaccines, Synthetic - genetics
Vaccines, Synthetic - immunology
Online AccessGet full text
ISSN1476-0584
1744-8395
1744-8395
DOI10.1586/erv.11.151

Cover

Abstract Recombinant hepatitis B vaccines are of the A2 genotype; one of ten known genotypes whose distribution varies globally. Reports of rare HBV infections in blood donors with an imbalance of non-A2 genotype HBV in vaccinated subjects have raised questions about the cross-protection afforded by HBV-A2 vaccines. Infections in HBV vaccinees were asymptomatic and transient, indicating that vaccination prevented clinical disease. Preclinical data demonstrate cross-reactivity and cross-protection by A2 vaccines against non-A2 HBV genotypes. Substantial improvements in HBV control have been demonstrated in countries with diverse genotype distribution that have introduced universal childhood HBV vaccination programs. Available data show that current HBV-A2 vaccines are highly effective in preventing infections and clinical disease caused by all known HBV genotypes.
AbstractList Recombinant hepatitis B vaccines are of the A2 genotype; one of ten known genotypes whose distribution varies globally. Reports of rare HBV infections in blood donors with an imbalance of non-A2 genotype HBV in vaccinated subjects have raised questions about the cross-protection afforded by HBV-A2 vaccines. Infections in HBV vaccinees were asymptomatic and transient, indicating that vaccination prevented clinical disease. Preclinical data demonstrate cross-reactivity and cross-protection by A2 vaccines against non-A2 HBV genotypes. Substantial improvements in HBV control have been demonstrated in countries with diverse genotype distribution that have introduced universal childhood HBV vaccination programs. Available data show that current HBV-A2 vaccines are highly effective in preventing infections and clinical disease caused by all known HBV genotypes.
Recombinant hepatitis B vaccines are of the A2 genotype; one of ten known genotypes whose distribution varies globally. Reports of rare HBV infections in blood donors with an imbalance of non-A2 genotype HBV in vaccinated subjects have raised questions about the cross-protection afforded by HBV-A2 vaccines. Infections in HBV vaccinees were asymptomatic and transient, indicating that vaccination prevented clinical disease. Preclinical data demonstrate cross-reactivity and cross-protection by A2 vaccines against non-A2 HBV genotypes. Substantial improvements in HBV control have been demonstrated in countries with diverse genotype distribution that have introduced universal childhood HBV vaccination programs. Available data show that current HBV-A2 vaccines are highly effective in preventing infections and clinical disease caused by all known HBV genotypes.Recombinant hepatitis B vaccines are of the A2 genotype; one of ten known genotypes whose distribution varies globally. Reports of rare HBV infections in blood donors with an imbalance of non-A2 genotype HBV in vaccinated subjects have raised questions about the cross-protection afforded by HBV-A2 vaccines. Infections in HBV vaccinees were asymptomatic and transient, indicating that vaccination prevented clinical disease. Preclinical data demonstrate cross-reactivity and cross-protection by A2 vaccines against non-A2 HBV genotypes. Substantial improvements in HBV control have been demonstrated in countries with diverse genotype distribution that have introduced universal childhood HBV vaccination programs. Available data show that current HBV-A2 vaccines are highly effective in preventing infections and clinical disease caused by all known HBV genotypes.
Audience Academic
Author Ridder, Marc De
Olivieri, Antonio
Leroux-Roels, Geert
Cassidy, Adrian
Mossman, Sally
Author_xml – sequence: 1
  givenname: Adrian
  surname: Cassidy
  fullname: Cassidy, Adrian
– sequence: 2
  givenname: Sally
  surname: Mossman
  fullname: Mossman, Sally
– sequence: 3
  givenname: Antonio
  surname: Olivieri
  fullname: Olivieri, Antonio
– sequence: 4
  givenname: Marc De
  surname: Ridder
  fullname: Ridder, Marc De
– sequence: 5
  givenname: Geert
  surname: Leroux-Roels
  fullname: Leroux-Roels, Geert
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22085174$$D View this record in MEDLINE/PubMed
BookMark eNp9ksuKFDEUhoOMOBfd-AASdKEI1SaVS6WWM8OMLQy6UbchlTppM1QnbZJu6bc3RY-CQyNZ5BC-_1zyn3N0EmIAhF5SsqBCyQ-QdgtKa0yfoDPacd4o1ouTGvNONkQoforOc74nhPFedM_QadsSJSp5hj4vYWOKLz7jK7wz1voAGJwDW_wOAuSMfcDlB2BnLODo8GqKg5nw8uo7XkGIZb8BPFY2ZV_2z9FTZ6YMLx7uC_Tt9ubr9bK5-_Lx0_XlXWMlkaWhgvWuVYMZleAwSuDUdc5wOfSSm1apkcrBEiOtI6AstYTLjraEthV3pGcX6O0h7ybFn1vIRa99tjBNJkDcZt0TIWUdUVXy3X9JSua_6BgRFX39CL2P2xTqHDUfJy3rGKvQmwO0MhNoH1wsydg5p75sFVO9ImSuujhC1TPC2ttqn_P1_R_Bq4fa22ENo94kvzZpr_84VYH3B8CmmHMC9xehRM9roOsaaEprTCtMHsHWl2pzDLUNPx2XiINkbjatza-YplEXs59icskE67NmR3S_ATBRw8c
CitedBy_id crossref_primary_10_1016_j_ymeth_2017_08_005
crossref_primary_10_2471_BLT_17_205153
crossref_primary_10_1007_s11262_020_01773_1
crossref_primary_10_2169_internalmedicine_5090_20
crossref_primary_10_2217_fvl_2016_0025
crossref_primary_10_4254_wjh_v13_i8_853
crossref_primary_10_3390_v15112186
crossref_primary_10_1002_hep_29876
crossref_primary_10_1186_s40798_022_00517_9
crossref_primary_10_1586_17474124_2015_960398
crossref_primary_10_1186_s12889_016_3459_1
crossref_primary_10_1371_journal_pone_0097759
crossref_primary_10_3389_fimmu_2021_745541
crossref_primary_10_1021_acsbiomaterials_3c01154
crossref_primary_10_3748_wjg_v21_i23_7074
crossref_primary_10_1111_jvh_13052
crossref_primary_10_3923_ijv_2015_133_138
crossref_primary_10_1002_jmv_24942
crossref_primary_10_30895_2221_996X_2021_21_3_142_157
crossref_primary_10_4254_wjh_v13_i12_1875
crossref_primary_10_1016_j_aohep_2019_06_005
crossref_primary_10_1371_journal_pone_0118062
crossref_primary_10_2957_kanzo_56_675
crossref_primary_10_4103_ijmr_IJMR_1852_16
crossref_primary_10_5812_hepatmon_14178
crossref_primary_10_1038_cgt_2013_65
crossref_primary_10_1111_imj_15069
crossref_primary_10_2174_1874357901812010033
crossref_primary_10_1016_j_vaccine_2016_04_013
crossref_primary_10_1016_j_jviromet_2017_01_016
crossref_primary_10_1002_path_4938
crossref_primary_10_1016_j_bj_2021_11_007
crossref_primary_10_1089_vim_2021_0058
crossref_primary_10_4254_wjh_v7_i6_819
crossref_primary_10_1007_s00535_017_1316_3
crossref_primary_10_1016_j_heliyon_2024_e37097
crossref_primary_10_1016_j_vaccine_2020_02_014
crossref_primary_10_3390_microorganisms11081908
crossref_primary_10_1016_j_vaccine_2021_05_067
crossref_primary_10_1080_17512433_2020_1814743
crossref_primary_10_3390_vaccines8030456
crossref_primary_10_1016_j_antiviral_2017_06_013
crossref_primary_10_1080_14760584_2017_1338568
crossref_primary_10_1097_QAD_0000000000003183
crossref_primary_10_31631_2073_3046_2017_16_4_65_72
crossref_primary_10_1590_1519_6984_245813
crossref_primary_10_3390_v12040427
crossref_primary_10_37349_emed_2021_00058
crossref_primary_10_1007_s00705_019_04332_8
crossref_primary_10_1111_trf_15393
crossref_primary_10_1016_j_dcit_2025_100040
crossref_primary_10_1111_jvh_13168
crossref_primary_10_1016_j_virusres_2016_04_022
crossref_primary_10_1155_2020_8848561
crossref_primary_10_1517_14712598_2013_789016
Cites_doi 10.1371/journal.pone.0009297
10.1128/JVI.00462-09
10.1177/0272989X9301300103
10.1093/ije/dyi206
10.3748/wjg.v17.i12.1549
10.1097/00001432-200210000-00002
10.1016/S0264-410X(99)00178-4
10.1111/j.1872-034X.2009.00601.x
10.1016/j.vaccine.2009.10.110
10.1099/vir.0.19749-0
10.1016/j.vaccine.2009.08.082
10.1128/JVI.02010-07
10.1002/jmv.1890160112
10.1093/jnci/dji043
10.1093/jnci/djp288
10.1111/j.1365-2893.2005.00624.x
10.1016/j.jcv.2011.06.020
10.1111/j.1440-1746.2004.03153.x
10.1111/j.1365-3156.2010.02560.x
10.1002/jmv.20884
10.1056/NEJMoa1007644
10.1016/j.antiviral.2008.03.006
10.1002/hep.24061
10.1111/j.1365-3156.2006.01709.x
10.1001/jama.1996.03540110060032
10.1001/archpedi.157.10.1025
10.1016/j.cld.2009.11.009
10.1111/j.1365-2893.2010.01312.x
10.1016/j.vaccine.2009.08.048
10.1016/j.jcv.2006.12.024
10.3748/wjg.v17.i12.1553
10.1016/j.vaccine.2008.09.056
10.1093/clinids/20.4.992
10.1590/S0102-311X2007001100023
10.1002/jmv.22129
10.1099/0022-1317-69-10-2575
10.1016/S1201-9712(03)90011-7
10.1046/j.1537-2995.2003.00392.x
10.1159/000096312
10.1136/gut.38.Suppl_2.S24
10.1016/S0264-410X(02)00116-0
10.1002/jmv.21522
10.1046/j.1440-1754.2001.00639.x
10.3748/wjg.v17.i12.1538
10.1086/599332
ContentType Journal Article
Copyright Expert Reviews Ltd 2011
COPYRIGHT 2011 Expert Reviews Ltd.
2011 Expert Reviews Ltd
Copyright_xml – notice: Expert Reviews Ltd 2011
– notice: COPYRIGHT 2011 Expert Reviews Ltd.
– notice: 2011 Expert Reviews Ltd
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8AO
8C1
8FI
8FJ
8FK
ABUWG
AFKRA
AN0
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
7U9
H94
7X8
DOI 10.1586/erv.11.151
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
British Nursing Database (Proquest)
ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni)
Medical Database
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Public Health
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
British Nursing Index with Full Text
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Pharma Collection
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
AIDS and Cancer Research Abstracts
Virology and AIDS Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic


ProQuest Public Health
AIDS and Cancer Research Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1744-8395
EndPage 1715
ExternalDocumentID 2512059571
A283898008
22085174
10_1586_erv_11_151
11217467
Genre Article
Journal Article
Review
GroupedDBID ---
0BK
0VX
29G
3V.
4.4
53G
5GY
7X7
88E
8AO
8C1
8FI
8FJ
AAOUU
ABEIZ
ABJNI
ABJXJ
ABLKL
ABUWG
ABXYU
ACGFS
ACNPW
ADBBV
ADCVX
AECIN
AENEX
AEOZL
AESAV
AFKRA
AGDLA
AGMLL
AHMBA
AIJEM
AIYSM
AKBVH
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALQZU
AN0
BENPR
BLEHA
BNQBC
BPHCQ
BVXVI
CCCUG
CCPQU
CS3
DU5
EBS
F5P
FYUFA
H13
HMCUK
HZ~
IAO
IEA
IHR
ITC
KYCEM
M1P
M4Z
MV1
O9-
OVD
P2P
PQQKQ
PROAC
PSQYO
RFE
RNANH
SJN
TBQAZ
TCNNB
TDBHL
TEORI
TFL
TFW
TUROJ
UKHRP
0YH
AAGSP
AAHJP
AANCX
AAYXX
ABKMU
ACFRI
ADTKB
AFRVT
CBZEQ
CITATION
DDEWX
DGYZD
EJD
GROUPED_DOAJ
LJTGL
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PMFND
7XB
8FK
K9.
PKEHL
PQEST
PQUKI
7U9
H94
7X8
ID FETCH-LOGICAL-c606t-1539f28bad854ed6e41f7fa46b964a288d16bc0a6cf0e8c1c04671201254ef093
IEDL.DBID 7X7
ISSN 1476-0584
1744-8395
IngestDate Tue Aug 05 10:04:59 EDT 2025
Fri Jul 11 15:31:19 EDT 2025
Fri Jul 25 05:48:16 EDT 2025
Tue Jun 17 21:39:49 EDT 2025
Tue Jun 10 20:50:07 EDT 2025
Mon Jul 21 05:27:06 EDT 2025
Tue Jul 01 03:24:53 EDT 2025
Thu Apr 24 23:11:10 EDT 2025
Wed Dec 25 09:03:21 EST 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c606t-1539f28bad854ed6e41f7fa46b964a288d16bc0a6cf0e8c1c04671201254ef093
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-3
ObjectType-Review-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ObjectType-Review-3
OpenAccessLink https://dipot.ulb.ac.be/dspace/bitstream/2013/196369/3/Hep_B_VE_globally_independant_genotype.pdf
PMID 22085174
PQID 904023733
PQPubID 54580
PageCount 7
ParticipantIDs proquest_miscellaneous_905668518
crossref_citationtrail_10_1586_erv_11_151
informaworld_taylorfrancis_310_1586_erv_11_151
gale_infotracacademiconefile_A283898008
crossref_primary_10_1586_erv_11_151
proquest_miscellaneous_1020857305
gale_infotracmisc_A283898008
proquest_journals_904023733
pubmed_primary_22085174
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 12/1/2011
2011-12-00
2011-Dec
20111201
PublicationDateYYYYMMDD 2011-12-01
PublicationDate_xml – month: 12
  year: 2011
  text: 12/1/2011
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Expert review of vaccines
PublicationTitleAlternate Expert Rev Vaccines
PublicationYear 2011
Publisher Taylor & Francis
Expert Reviews Ltd
Informa Healthcare
Publisher_xml – name: Taylor & Francis
– name: Expert Reviews Ltd
– name: Informa Healthcare
References Yu (CIT0052) 2005; 97
Kane (CIT0006) 2002; 15
Zanetti (CIT0013) 2008; 26
MacIntyre (CIT0010) 2001; 37
Poovorawan (CIT0036) 2011; 18
Viviani (CIT0040) 1999; 17
McMahon (CIT0049) 2011
Liang (CIT0038) 2009; 27
Ramírez Albajés (CIT0045) 2000; 19
Shokrgozar (CIT0017) 2002; 20
Hauser (CIT0016) 1987; 63
(CIT0005) 1992; 67
Tran (CIT0022) 2008; 82
(CIT0004) 1988; 66
Chan (CIT0030) 2004; 19
Chen (CIT0033) 1996; 276
Te (CIT0019) 2010; 14
Dong (CIT0037) 2009; 81
Jackson (CIT0056) 2003; 43
Duarte (CIT0046) 2010; 15
Kurbanov (CIT0018) 2010; 40
Kramvis (CIT0024) 2005; 12
Purdy (CIT0014) 2007; 50
Hung (CIT0009) 2009; 27
Chongsrisawat (CIT0034) 2006; 11
CIT0007
Nunes (CIT0047) 2007; 23
CIT0008
Bhimma (CIT0042) 2003; 157
Gutiérrez-García (CIT0054) 2011; 17
Hollinger (CIT0011) 1996; 38
Hyams (CIT0003) 1995; 20
Liang (CIT0039) 2009; 200
Ocana (CIT0053) 2011; 17
(CIT0001) 2010; 28
Venegas (CIT0048) 2011; 83
Kim (CIT0027) 2008; 79
Kimbi (CIT0041) 2004; 85
CIT0021
Tacke (CIT0043) 2007; 38
O’Halloran (CIT0044) 2011; 52
Romero (CIT0055) 2011; 17
Daniels (CIT0050) 2009; 58
Iwarson (CIT0028) 1985; 16
Chang (CIT0032) 2009; 101
Krahn (CIT0012) 1993; 13
Okamoto (CIT0015) 1988; 69
Wen (CIT0031) 2011; 53
Stramer (CIT0025) 2011; 364
Schellekens (CIT0029) 1987; 63
Inui (CIT0051) 2007; 79
Goldstein (CIT0002) 2005; 34
Yu (CIT0020) 2010; 5
Tatematsu (CIT0023) 2009; 83
CIT0026
Wichajarn (CIT0035) 2008; 9
Expert Rev Vaccines. 2012 Jan;11(1):120
References_xml – volume: 5
  start-page: e9297
  year: 2010
  ident: CIT0020
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0009297
– volume: 83
  start-page: 10538
  year: 2009
  ident: CIT0023
  publication-title: J. Virol.
  doi: 10.1128/JVI.00462-09
– volume: 13
  start-page: 4
  year: 1993
  ident: CIT0012
  publication-title: Med. Decis. Making
  doi: 10.1177/0272989X9301300103
– volume: 34
  start-page: 1329
  year: 2005
  ident: CIT0002
  publication-title: Int. J. Epidemiol.
  doi: 10.1093/ije/dyi206
– ident: CIT0021
– volume: 17
  start-page: 1549
  year: 2011
  ident: CIT0055
  publication-title: World J. Gastroenterol.
  doi: 10.3748/wjg.v17.i12.1549
– volume: 67
  start-page: 11
  year: 1992
  ident: CIT0005
  publication-title: Wkly Epidemiol. Rec.
– volume: 15
  start-page: 465
  year: 2002
  ident: CIT0006
  publication-title: Curr. Opin. Infect. Dis.
  doi: 10.1097/00001432-200210000-00002
– volume: 17
  start-page: 2946
  year: 1999
  ident: CIT0040
  publication-title: Vaccine
  doi: 10.1016/S0264-410X(99)00178-4
– volume: 19
  start-page: 82
  year: 2000
  ident: CIT0045
  publication-title: Rev.Cubana. Invest. Biomed.
– volume: 40
  start-page: 14
  year: 2010
  ident: CIT0018
  publication-title: Hepatol. Res.
  doi: 10.1111/j.1872-034X.2009.00601.x
– volume: 28
  start-page: 589
  year: 2010
  ident: CIT0001
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2009.10.110
– volume: 85
  start-page: 1211
  year: 2004
  ident: CIT0041
  publication-title: J. Gen. Virol.
  doi: 10.1099/vir.0.19749-0
– volume: 27
  start-page: 6770
  year: 2009
  ident: CIT0009
  publication-title: Vaccine.
  doi: 10.1016/j.vaccine.2009.08.082
– volume: 82
  start-page: 5657
  year: 2008
  ident: CIT0022
  publication-title: J. Virol.
  doi: 10.1128/JVI.02010-07
– year: 2011
  ident: CIT0049
  publication-title: Hepatology
– volume: 16
  start-page: 89
  year: 1985
  ident: CIT0028
  publication-title: J. Med. Virol.
  doi: 10.1002/jmv.1890160112
– volume: 97
  start-page: 265
  year: 2005
  ident: CIT0052
  publication-title: J. Natl Cancer Inst.
  doi: 10.1093/jnci/dji043
– ident: CIT0008
– volume: 101
  start-page: 1348
  year: 2009
  ident: CIT0032
  publication-title: J. Natl Cancer Inst.
  doi: 10.1093/jnci/djp288
– volume: 63
  start-page: 93
  year: 1987
  ident: CIT0029
  publication-title: Postgrad. Med. J.
– volume: 12
  start-page: 456
  year: 2005
  ident: CIT0024
  publication-title: J. Viral Hepat.
  doi: 10.1111/j.1365-2893.2005.00624.x
– ident: CIT0026
– volume: 52
  start-page: 151
  year: 2011
  ident: CIT0044
  publication-title: J. Clin. Virol.
  doi: 10.1016/j.jcv.2011.06.020
– volume: 19
  start-page: 121
  year: 2004
  ident: CIT0030
  publication-title: J. Gastroenterol. Hepatol.
  doi: 10.1111/j.1440-1746.2004.03153.x
– volume: 15
  start-page: 924
  year: 2010
  ident: CIT0046
  publication-title: Trop. Med. Int. Health
  doi: 10.1111/j.1365-3156.2010.02560.x
– volume: 58
  start-page: 1
  year: 2009
  ident: CIT0050
  publication-title: MMWR Surveill. Summ.
– volume: 79
  start-page: 670
  year: 2007
  ident: CIT0051
  publication-title: J. Med. Virol.
  doi: 10.1002/jmv.20884
– volume: 364
  start-page: 236
  year: 2011
  ident: CIT0025
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1007644
– volume: 79
  start-page: 188
  year: 2008
  ident: CIT0027
  publication-title: Antiviral Res.
  doi: 10.1016/j.antiviral.2008.03.006
– volume: 53
  start-page: 429
  year: 2011
  ident: CIT0031
  publication-title: Hepatology
  doi: 10.1002/hep.24061
– volume: 11
  start-page: 1496
  year: 2006
  ident: CIT0034
  publication-title: Trop. Med. Int. Health
  doi: 10.1111/j.1365-3156.2006.01709.x
– volume: 276
  start-page: 906
  year: 1996
  ident: CIT0033
  publication-title: JAMA
  doi: 10.1001/jama.1996.03540110060032
– volume: 157
  start-page: 1025
  year: 2003
  ident: CIT0042
  publication-title: Arch. Pediatr. Adolesc. Med.
  doi: 10.1001/archpedi.157.10.1025
– volume: 14
  start-page: 1
  year: 2010
  ident: CIT0019
  publication-title: Clin. Liver Dis.
  doi: 10.1016/j.cld.2009.11.009
– volume: 18
  start-page: 369
  year: 2011
  ident: CIT0036
  publication-title: J. Viral Hepat.
  doi: 10.1111/j.1365-2893.2010.01312.x
– volume: 27
  start-page: 6550
  year: 2009
  ident: CIT0038
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2009.08.048
– volume: 38
  start-page: 353
  year: 2007
  ident: CIT0043
  publication-title: J. Clin. Virol.
  doi: 10.1016/j.jcv.2006.12.024
– volume: 17
  start-page: 1553
  year: 2011
  ident: CIT0053
  publication-title: World J. Gastroenterol.
  doi: 10.3748/wjg.v17.i12.1553
– volume: 26
  start-page: 6266
  year: 2008
  ident: CIT0013
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2008.09.056
– volume: 20
  start-page: 992
  year: 1995
  ident: CIT0003
  publication-title: Clin. Infect. Dis.
  doi: 10.1093/clinids/20.4.992
– volume: 23
  start-page: 2756
  year: 2007
  ident: CIT0047
  publication-title: Cad. Saude Publica
  doi: 10.1590/S0102-311X2007001100023
– volume: 9
  start-page: 507
  year: 2008
  ident: CIT0035
  publication-title: Asian Pac. J. Cancer Prev.
– volume: 83
  start-page: 1530
  year: 2011
  ident: CIT0048
  publication-title: J. Med. Virol.
  doi: 10.1002/jmv.22129
– volume: 69
  start-page: 2575
  year: 1988
  ident: CIT0015
  publication-title: J. Gen. Virol.
  doi: 10.1099/0022-1317-69-10-2575
– ident: CIT0007
  doi: 10.1016/S1201-9712(03)90011-7
– volume: 43
  start-page: 721
  year: 2003
  ident: CIT0056
  publication-title: Transfusion
  doi: 10.1046/j.1537-2995.2003.00392.x
– volume: 50
  start-page: 45
  year: 2007
  ident: CIT0014
  publication-title: Intervirology
  doi: 10.1159/000096312
– volume: 38
  start-page: S24
  year: 1996
  ident: CIT0011
  publication-title: Gut
  doi: 10.1136/gut.38.Suppl_2.S24
– volume: 20
  start-page: 2215
  year: 2002
  ident: CIT0017
  publication-title: Vaccine
  doi: 10.1016/S0264-410X(02)00116-0
– volume: 81
  start-page: 1517
  year: 2009
  ident: CIT0037
  publication-title: J. Med. Virol.
  doi: 10.1002/jmv.21522
– volume: 37
  start-page: 215
  year: 2001
  ident: CIT0010
  publication-title: J. Paediatr. Child Health
  doi: 10.1046/j.1440-1754.2001.00639.x
– volume: 66
  start-page: 443
  year: 1988
  ident: CIT0004
  publication-title: Bull. World Health Organ.
– volume: 17
  start-page: 1538
  year: 2011
  ident: CIT0054
  publication-title: World J. Gastroenterol.
  doi: 10.3748/wjg.v17.i12.1538
– volume: 63
  start-page: S83
  year: 1987
  ident: CIT0016
  publication-title: Postgrad. Med. J.
– volume: 200
  start-page: 39
  year: 2009
  ident: CIT0039
  publication-title: J. Infect. Dis.
  doi: 10.1086/599332
– reference: - Expert Rev Vaccines. 2012 Jan;11(1):120
SSID ssj0034957
Score 2.216728
SecondaryResourceType review_article
Snippet Recombinant hepatitis B vaccines are of the A2 genotype; one of ten known genotypes whose distribution varies globally. Reports of rare HBV infections in blood...
SourceID proquest
gale
pubmed
crossref
informaworld
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1709
SubjectTerms Blood donors
Children
Cross-protection
Cross-reactivity
Data processing
Development and progression
effectiveness
Genetic aspects
Genetic Variation
Genotype
Genotypes
Health aspects
Hepatitis B
Hepatitis B - blood
Hepatitis B - immunology
Hepatitis B - prevention & control
Hepatitis B - virology
Hepatitis B Antibodies - blood
Hepatitis B Antibodies - immunology
Hepatitis B vaccine
Hepatitis B Vaccines - administration & dosage
Hepatitis B Vaccines - genetics
Hepatitis B Vaccines - immunology
Hepatitis B virus
Hepatitis B virus - genetics
Hepatitis B virus - immunology
Hepatitis B virus - pathogenicity
Humans
Infection
Prevention
recombinant vaccine
Reviews
Vaccination
vaccine
Vaccines
Vaccines, Synthetic - administration & dosage
Vaccines, Synthetic - genetics
Vaccines, Synthetic - immunology
Title Hepatitis B vaccine effectiveness in the face of global HBV genotype diversity
URI https://www.tandfonline.com/doi/abs/10.1586/erv.11.151
https://www.ncbi.nlm.nih.gov/pubmed/22085174
https://www.proquest.com/docview/904023733
https://www.proquest.com/docview/1020857305
https://www.proquest.com/docview/905668518
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9wwEB7ahEIvJW36cPNApYHSgxs_tLJ0CtmQsBS6hNCUvQlZDwgUb9p1Cv33mZG1pgtJL4vB2pV3NPr0ffJoBuAoIOJJRee2pJI595bn0nGXK45awxatN_GQ2Le5mF3zr4vJIsXmrFJY5RoTI1C7paU98mOF3lbVTV2f3P7KqWgUvVxNFTSewjZlLqOIrmYx6q0auX-srcIbFM240KbspBMpjnEeIljgdbmxHiVU3kha-jj1jEvQxQ68SNyRnQ6D_RKe-O4VPBuqSf7dhfnMU3h0f7NiU_bHWHplzoZ4jQRp7KZjSPhYMNazZWBDNhA2m_5glKuVtmOZWwdqvIbri_PvZ7M8lUvILaqQPkfsUqGSrXFywr0TnpehCYaLVgluKildKVpbGGFD4aUtLUrjpkQCgBrRh0LVb2CrW3b-HbDC2raxAcFworhrrGqDrxpTOoWrvfAyg89ro2mbcolTSYufmjQFGlijgVFc4HWZwcex7e2QQePBVp_I9posj79kTTodgM9DCar0KdIg9CZkLBnsb7TE6WA3bn_5d_R0Hzc-wlClRNcP9by3Hl-d5u9Kj96WwYfxLvVEIWmdX96t8D_E8qaIlxmwR9oopJcCOS0-1dvBc0YTVPRtlIPv_9v9HjyPm9gxfmYftvrfd_4AWVDfHkZfx095Vh7C9vR8fnl1D0V_BvM
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1NT9wwEB2hRVV7qfrdAKWu2qrqIbBJvIl9QIhtQaHAqqqg4uY6ji0hVVnohlb8qP7HPudjxUrQG7dI8a6T8fj5PWc8Q_TOAfGE9Oe2hBQht4aHouRlKDm0hhkWVjeHxI4maX7Cv5yOTpfob38WxodV9pjYAHU5NX6PfFPC2-IkS5Lt84vQF43yH1f7ChqtVxzYqz9QbLOt_c8Y3vdxvLd7_CkPu6ICoQFXr0PMcOliUehSjLgtU8sjlznN00KmXMdClFFamKFOjRtaYSIDAZlFWCahpKxrci8B8Zd5AiUzoOXx7uTrtx76E6iNppoLzyDTsbR3-VBHIt3EzAc84TpaWAG7dWAhTertZLdZ9PYe0cOOrbKd1r0e05KtntC9tn7l1VOa5NYHZNdnMzZmv7XxH-lZGyHSgSg7qxgoJnPaWDZ1rM0_wvLxd-azw_oNYFb2oSHP6ORObPmcBtW0si-JDY0pMuMAvyPJy8zIwtk401EpwS9SKwL62BtNmS57uS-i8VN5FQMDKxgYcgbXUUBv523P25wdN7b64G2vvOXxT0Z35xHwPD4lltoB8YL_giMFtLbQEhPQLNzeuD56qm62WlxbF0UlN_W82o-v6hBjpub-HdCb-V3fkw-Cq-z0coZ3aAqqAqEDYre0kSC0KVg0nupF6zlzE8T-1xCgK__t_jXdz4-PDtXh_uRglR40W-hN9M4aDepfl_YVOFhdrHeez-jHXU-2f1LMQik
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Nb9QwEB1VRSAuFd8NLWAECHEIu0mcxD4g1FJWWworDhTtzSSOLVVC2babtupP49_x7HyIlVpuvUWKd52MZ97Mc8YzRK8tEE9Id25LSBFyo3koKl6FkoNr6HFpCn9I7Nssmx7yL_N0vkZ_-rMwLq2yx0QP1NVCuz3ykYS2xUmeJCPbZUV835t8PD4JXQMp96G176bRasiBubwAe1t-2N_DUr-J48nnH5-mYddgINSI25sQ1i5tLMqiEik3VWZ4ZHNb8KyUGS9iIaooK_W4yLQdG6EjDTKZR3CZYFXG-jpMQP9beZJGzsTy-cD1EvAO39eF5yDscPJdZdRUZCNgAIAK19GKL-w8wkrB1OvDXu_-Jvdoo4tb2U6raPdpzdQP6HbbyfLyIc2mxqVmN0dLtsvOC-0-17M2V6SDU3ZUMwSbzBbasIVlbSUSNt39yVydWLcVzKo-SeQRHd6IJB_Ter2ozSaxsdZlri2AOJW8yrUsrYnzIqokIo3MiIDe9UJTuqtj7tpp_FaOz0DACgIGscF1FNCrYexxW73jylFvneyVkzz-SRfdyQQ8jyuOpXYQgkGTES0FtL0yEqaoV26__3f1VOM3XWzbIUUlV8281a-v6rBjqQZND-jlcNfN5NLharM4W-IdfGtVYHVA7JoxEqFthngaT_Wk1ZxBBLH7Najo0_9O_4LuwMTU1_3ZwRbd9XvpPo1nm9ab0zPzDMFYUz73as_o103b2V_Wo0T5
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hepatitis+B+vaccine+effectiveness+in+the+face+of+global+HBV+genotype+diversity&rft.jtitle=Expert+review+of+vaccines&rft.au=Cassidy%2C+Adrian&rft.au=Mossman%2C+Sally&rft.au=Olivieri%2C+Antonio&rft.au=Ridder%2C+Marc+De&rft.date=2011-12-01&rft.pub=Expert+Reviews+Ltd&rft.issn=1476-0584&rft.volume=10&rft.issue=12&rft.spage=1709&rft_id=info:doi/10.1586%2Ferv.11.151&rft.externalDocID=A283898008
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1476-0584&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1476-0584&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1476-0584&client=summon